Therapeutic cancers cdk6. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Dendritic Cells Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Breast HCT116 Cells Cell Line

Organisms1

Diseases30

Neoplasms Prostatic Neoplasms Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Colonic Neoplasms Stomach Neoplasms Neoplasm Invasiveness Neoplasm Metastasis Pancreatic Neoplasms Uterine Cervical Neoplasms Genetic Predisposition to Disease Carcinoma, Squamous Cell Carcinoma Disease Progression Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Cell Transformation, Neoplastic Rectal Neoplasms Neoplasm Recurrence, Local Endometrial Neoplasms Esophageal Neoplasms Liver Neoplasms Adenocarcinoma Neoplasms, Hormone-Dependent Head and Neck Neoplasms Mouth Neoplasms Carcinoma, Small Cell Bone Neoplasms

Chemicals and Drugs48

Cancer Vaccines Antigens, Neoplasm Tissue Extracts Cyclin-Dependent Kinases Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinase 5 Cyclin-Dependent Kinase 4 CDC2-CDC28 Kinases Cyclin-Dependent Kinase 6 Neoplasm Proteins CDC2 Protein Kinase Cyclins Antineoplastic Agents Cell Cycle Proteins Protein-Serine-Threonine Kinases RNA, Messenger Cyclin-Dependent Kinase Inhibitor p27 Tumor Suppressor Proteins Receptors, Estrogen RNA, Small Interfering Tumor Markers, Biological Cyclin E Tumor Suppressor Protein p53 Cyclin-Dependent Kinase 9 Receptor, erbB-2 Proto-Oncogene Proteins DNA, Neoplasm Cyclin D1 Prostate-Specific Antigen Cyclin-Dependent Kinase Inhibitor p21 Tamoxifen Fluorouracil Antineoplastic Agents, Phytogenic Cisplatin Nuclear Proteins Receptors, Progesterone Antineoplastic Agents, Hormonal DNA-Binding Proteins Anticarcinogenic Agents Protein Kinase Inhibitors Enzyme Inhibitors Cyclin-Dependent Kinase 8 Paclitaxel Transcription Factors Cyclin D Cyclin-Dependent Kinase Inhibitor p16 MicroRNAs Receptor, Epidermal Growth Factor

Analytical, Diagnostic and Therapeutic Techniques and Equipment38

Immunotherapy Clinical Trials as Topic Early Detection of Cancer Survival Analysis Survival Rate Reverse Transcriptase Polymerase Chain Reaction Prognosis Antineoplastic Combined Chemotherapy Protocols Blotting, Western Gene Expression Profiling Risk Xenograft Model Antitumor Assays Follow-Up Studies Retrospective Studies Registries Prospective Studies Neoplasm Staging Risk Assessment Neoplasm Transplantation Disease-Free Survival Combined Modality Therapy Odds Ratio Transfection Transplantation, Heterologous Chemotherapy, Adjuvant Oligonucleotide Array Sequence Analysis Sensitivity and Specificity Models, Biological Drug Screening Assays, Antitumor Kaplan-Meier Estimate Mammography Multivariate Analysis Risk Factors Polymerase Chain Reaction Tumor Burden Questionnaires SEER Program Molecular Targeted Therapy

Psychiatry and Psychology1

Phenomena and Processes32

Cell Cycle Gene Expression Regulation, Neoplastic Phosphorylation Mutation Genetic Predisposition to Disease Drug Resistance, Neoplasm Risk Cell Division G1 Phase Down-Regulation Cell Proliferation Cell Survival Apoptosis Odds Ratio DNA Methylation Transfection Cell Movement RNA Interference Promoter Regions, Genetic Genotype Sensitivity and Specificity Cell Growth Processes Genes, BRCA1 S Phase Dose-Response Relationship, Drug Signal Transduction Up-Regulation Polymorphism, Genetic Base Sequence Genes, Tumor Suppressor Gene Silencing Protein Binding

Disciplines and Occupations1

Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science6

Survival Rate Registries Molecular Sequence Data Questionnaires SEER Program Base Sequence

Named Groups1

Health Care19

Clinical Trials as Topic Survival Analysis Survival Rate National Cancer Institute (U.S.)Risk Follow-Up Studies Retrospective Studies Registries Prospective Studies Risk Assessment Disease-Free Survival Age Factors Odds Ratio Sensitivity and Specificity Kaplan-Meier Estimate Multivariate Analysis Risk Factors Questionnaires SEER Program

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Cancer Vaccines Antigens, Neoplasm Tissue Extracts Immunotherapy Neoplasms Clinical Trials as Topic Prostatic Neoplasms Dendritic Cells Cyclin-Dependent Kinases Early Detection of Cancer Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinase 5 Cyclin-Dependent Kinase 4 Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Colonic Neoplasms Stomach Neoplasms CDC2-CDC28 Kinases Cell Cycle Neoplasm Invasiveness Neoplasm Metastasis Gene Expression Regulation, Neoplastic Pancreatic Neoplasms Mice, Nude Cyclin-Dependent Kinase 6 Neoplasm Proteins CDC2 Protein Kinase Cell Line, Tumor Cyclins Phosphorylation Antineoplastic Agents Cell Cycle Proteins Uterine Cervical Neoplasms Mutation Survival Analysis Genetic Predisposition to Disease Survival Rate Protein-Serine-Threonine Kinases Reverse Transcriptase Polymerase Chain Reaction Drug Resistance, Neoplasm Prognosis Carcinoma, Squamous Cell RNA, Messenger Carcinoma Antineoplastic Combined Chemotherapy Protocols Disease Progression Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Blotting, Western National Cancer Institute (U.S.)Gene Expression Profiling Risk Cyclin-Dependent Kinase Inhibitor p27 Xenograft Model Antitumor Assays Tumor Suppressor Proteins Colorectal Neoplasms Follow-Up Studies Receptors, Estrogen RNA, Small Interfering Retrospective Studies Cell Division Tumor Markers, Biological Cyclin E Registries Tumor Suppressor Protein p53 Cyclin-Dependent Kinase 9 Cell Transformation, Neoplastic Prospective Studies Receptor, erbB-2 Neoplasm Staging G1 Phase Survivors Proto-Oncogene Proteins Risk Assessment United States Rectal Neoplasms Neoplasm Recurrence, Local Down-Regulation Cell Proliferation DNA, Neoplasm Neoplasm Transplantation Cell Survival Disease-Free Survival Cyclin D1 Apoptosis Endometrial Neoplasms Combined Modality Therapy Prostate-Specific Antigen Cyclin-Dependent Kinase Inhibitor p21 Age Factors Odds Ratio DNA Methylation Transfection Tamoxifen Smoking Transplantation, Heterologous Chemotherapy, Adjuvant Tumor Cells, Cultured Esophageal Neoplasms

No FAQ available that match "therapeutic cancers cdk6"